BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy.
Saved in:
| Title: | BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy. |
|---|---|
| Authors: | Perez-Garcia, Georgina1,2 (AUTHOR), Bicak, Mesude3,4 (AUTHOR), Haure-Mirande, Jean-Vianney1 (AUTHOR), Perez, Gissel M.2 (AUTHOR), Otero-Pagan, Alena2 (AUTHOR), Gama Sosa, Miguel A.5,6 (AUTHOR), De Gasperi, Rita2,5 (AUTHOR), Sano, Mary2,5,7 (AUTHOR), Barlow, Carrolee8,9 (AUTHOR), Gage, Fred H.8,10 (AUTHOR), Readhead, Benjamin11 (AUTHOR), Ehrlich, Michelle E.1,3 (AUTHOR), Gandy, Sam1,2,5,7,12 (AUTHOR), Elder, Gregory A.1,5,7,13 (AUTHOR) gregory.elder@mssm.edu |
| Source: | Neuroscience Letters. Feb2023, Vol. 797, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
